Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
12/2012
12/06/2012US20120309772 Inhibitors of fatty acid uptake and methods of use
12/06/2012US20120309758 Modulators of atp-binding cassette transporters
12/06/2012US20120309732 METHOD FOR INHIBITION OF TUMOR CELL GROWTH USING (22R)-5alpha-LANOSTA-8,24-DIEN-3Beta,15alpha,21-TRIOL
12/06/2012US20120309730 Oxysterols that activate liver x receptor signaling and inhibit hedgehog signaling
12/06/2012US20120309704 Compositions for treatment of chemoresistant and/or potentially chemoresistant leukaemias
12/06/2012US20120309702 Dynamic inhibitors of heat shock protein 90
12/06/2012US20120309696 Acth antagonist peptides
12/06/2012US20120309689 Hatching fluid enzymes and uses thereof
12/06/2012US20120309684 Conjugates for delivery of biologically active compounds
12/06/2012US20120309671 Process for the measurement of the potency of glatiramer acetate
12/06/2012US20120309647 Patterning and cellular co-culture
12/06/2012US20120309092 Angiogenin Expression in Plants
12/06/2012US20120309091 Methods And Compositions For Gene Inactivation
12/06/2012US20120309090 Self contained solid phase photobioreactor
12/06/2012US20120309089 Supports for cell culture and cell sheet detachment and methods for cell sheet detachment
12/06/2012US20120309088 Methods and compositions for stem cell self-renewal
12/06/2012US20120309087 Cancer therapy
12/06/2012US20120309086 Methods and use of inducing apoptosis in cancer cells
12/06/2012US20120309085 Variant Forms of Urate Oxidase and Use Thereof
12/06/2012US20120309074 Novel xylanase produced from cellulosimicrobium funkei hy-13
12/06/2012US20120309067 Protease Variants
12/06/2012US20120309056 Fed-batch process using concentrated cell culture medium for the efficient production of biologics in eb66 cells
12/06/2012US20120309053 Three dimensional porous structures
12/06/2012US20120309052 Inducible baculovirus system in insect cells
12/06/2012US20120309051 Compositions and methods for preparing recombinant mg53 and methods for optimizing same
12/06/2012US20120309050 System for increasing gene expression and vector comprising the system
12/06/2012US20120309031 Antibodies that bind human dendritic and epithelial cell 205 (dec-205)
12/06/2012US20120308995 Vaccinia virus mutants containing the major genomic deletions of mva
12/06/2012US20120308987 Matrices and media for storage and stabilization of biomolecules
12/06/2012US20120308986 Method for producing nk cell-enriched blood product
12/06/2012US20120308985 Immature Reticulocyte Fraction Reference Control and Related Methods
12/06/2012US20120308647 Use of mir-30e to treat vascular lesions
12/06/2012US20120308645 Compositions and methods for sirna inhibition of hif-1 alpha
12/06/2012US20120308641 Compositions and Methods for Enhancing Coagulation Factor VIII Function
12/06/2012US20120308615 Formulation of hepatitis b virus antigens for cellular stimulation followed by therapeutic immunization
12/06/2012US20120308610 Materials and Methods for Altering an Immune Response to Exogenous and Endogenous Immunogens, Including Syngeneic and Non-Syngeneic Cells, Tissues or Organs
12/06/2012US20120308607 Production and use of human cd124- and cd-116-positive tumor cell lines in the production of allogenic or semi-allogenic immunotherapy agents
12/06/2012US20120308595 Novel Immunogenic Compositions For The Prevention And Treatment of Meningococcal Disease
12/06/2012US20120308594 Hcv clade and prototype sequences thereof
12/06/2012US20120308591 Tmem22 peptides and vaccines including the same
12/06/2012US20120308590 Imp-3 oligopeptides and vaccines including the same
12/06/2012US20120308585 Methods and compositions for use in cellular therapies
12/06/2012US20120308580 Hepatitus b virus specific antibody and usese thereof
12/06/2012US20120308575 Full human anti-tnf-alpha monoclonal antibody, preparation method and use thereof
12/06/2012US20120308572 Protofibril-Binding Antibodies and Their Use in Therapeutic and Diagnostic Methods for Parkinson's Disease, Dementia with Lewy Bodies and Other Alpha-Synucleinopathies
12/06/2012US20120308571 Anti-podoplanin antibody, and pharmaceutical composition containing anti-podoplanin antibody
12/06/2012US20120308570 Methods for treating diseases
12/06/2012US20120308569 Gene products differentially expressed in cancerous cells
12/06/2012US20120308563 Regulatory b cells (tbregs) and their use
12/06/2012US20120308554 Vegf-d/vegfr2/3-mediated regulation of dendrites
12/06/2012US20120308548 Methionine gamma lyase-2-aminobutyrate deaminase (megl-2abd) and therapeutic uses thereof
12/06/2012US20120308546 Polymers for reversing heparin-based anticoagulation
12/06/2012US20120308540 Modified factor IX polypeptides and uses thereof
12/06/2012US20120308537 Use Of Collagen Type VII For Maintaining And Re-Inducing Osteogenic Abilities Of Mesenchymal Stem Cells
12/06/2012US20120308536 Methods of using adipose tissue-derived cells in augmenting autologous fat transfer
12/06/2012US20120308535 Pharmaceutical Composition Containing Expanded Adult Stem Cells and Methods of Using Same for Treatment
12/06/2012US20120308534 Neural progenitor cell populations
12/06/2012US20120308533 Adipocyte sheet, three-dimensional structure thereof, and method for producing the same
12/06/2012US20120308531 Expansion of Stem Cells in Hollow Fiber Bioreactors
12/06/2012US20120308530 Materials Composition and Methods to Control Neural Progenitor and Stem Cell Attachment, Proliferation and Guide Cell Differentiation
12/06/2012US20120308521 Compositions and Methods for Treatment of Cancer Using Tissue-Specific Oncolytic Adenoviruses
12/06/2012US20120308518 Methods of using regenerative cells in the treatment of stroke and related diseases and disorders
12/06/2012US20120308515 Use of gilz protein expressed in dendritic cells to modulate an antigen-specific immune response
12/06/2012US20120308513 Promiscuous her-2/neu cd4 t cell epitopes
12/06/2012US20120308482 Monkey Homolog of Human Interferon Omega
12/06/2012US20120308479 Brain Endothelial Cell Expression Patterns
12/06/2012US20120308478 Antibodies specific for claudin 6 (cldn6)
12/06/2012DE102011103457A1 Implantable biological joint replacement for shoulder and hip for treating osteoarthritis, has movement unit comprising support which determines depth of milling process, or bracket which sets pressure of walker
12/06/2012CA2837898A1 Method of treating the effects of stroke
12/06/2012CA2837895A1 Methods of treating or preventing neurological diseases
12/06/2012CA2837654A1 Methods and uses for ex vivo tissue culture systems
12/06/2012CA2837518A1 Biomarkers for in vitro prognosis and diagnosis of graft and transplant rejection
12/06/2012CA2837462A1 Bioartificial proximal tubule systems and methods of use
12/06/2012CA2837279A1 Mutant replicon derived from genome of hepatitis c virus j6cf strain
12/06/2012CA2836608A1 Microfluidic cell trap and assay apparatus for high-throughput analysis
12/05/2012EP2530165A1 Method for producing pyripyropene derivative by enzymatic process
12/05/2012EP2530164A1 Method for manufacturing a pyripyropene
12/05/2012EP2530163A1 Double marker cell line
12/05/2012EP2530146A1 Immunomodulation using placental stem cells
12/05/2012EP2530145A1 Immunomodulation using placental stem cells
12/05/2012EP2530144A2 Composition comprising cell and biocompatible polymer
12/05/2012EP2530143A1 Method for the identification and purification of human naturally occurring regulatory t cells (ntregs)
12/05/2012EP2530142A1 Perfusion culture method and perfusion culture device for organ or tissue
12/05/2012EP2530092A1 Antibody capable of discriminating the change in structure between antibody conjugated with antibody and antibody unconjugated with antibody, and method for production of the antibody
12/05/2012EP2530090A2 Anti-IL-13R alpha 1 antibodies and their uses thereof
12/05/2012EP2529238A2 Hanging drop devices, systems and/or methods
12/05/2012EP2529021A1 An inducible baculovirus system in insect cells
12/05/2012EP2529009A1 Method for stem cell differentiation
12/05/2012EP2529008A1 Tools for isolating and following cardiovascular progenitor cells
12/05/2012EP2529007A1 Treatment of bone-related cancers using placental stem cells
12/05/2012EP2529006A2 Methods&compositions for improving protein production
12/05/2012EP2529005A1 Use of hydrogels on the basis of guluronic acid- and/or mannuronic acid-containing polysaccharides for treating damage to the nervous system, promoting nerve growth, treating neurodegenerative diseases and cultivating neurons
12/05/2012EP2528633A2 Osteogenic cell delivery matrix
12/05/2012CN102812125A Novel lipoxygenases derived from lemna paucicostata
12/05/2012CN102812123A Methods and systems for reducing dna fragmentation in a processed sperm sample
12/05/2012CN102812122A Generation Of Genetically Corrected Disease-free Induced Pluripotent Stem Cells
12/05/2012CN102812121A Methods & compositions for improving protein production
12/05/2012CN102812117A Perfusion culture method and perfusion culture device for organ or tissue
12/05/2012CN102808016A Applications of ARID1A gene and protein product encoded by the same
12/05/2012CN102808014A Determination method for identifying effect of kidney governing bones by using in vitro cell culture manner
1 ... 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 ... 1827